🇺🇸 FDA
Patent

US 7285527

Tumor radiosensitization using gene therapy

granted A61KA61K38/193A61K38/202

Quick answer

US patent 7285527 (Tumor radiosensitization using gene therapy) held by The Regents of the University of California expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/193, A61K38/202, A61K39/0011, A61K48/00